Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lyudmila Boyanova, Georgi Dimitrov, Raina Gergova, Petyo Hadzhiyski & Rumyana Markovska. (2023) Clostridioides difficile resistance to antibiotics, including post-COVID-19 data. Expert Review of Clinical Pharmacology 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (4)
Xiao-hong Yu, Zhi Lv, Cong-en Zhang, Yan Gao, Hui Li, Xiao-jing Ma, Zhi-jie Ma, Jian-rong Su & Lu-qi Huang. (2024) Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism. Journal of Ethnopharmacology 320, pages 117384.
Crossref
Crossref
Jacob M. Furlon, Spencer J. Mitchell, Chris Bailey‐Kellogg & Karl E. Griswold. (2021)
Bioinformatics‐driven discovery of novel
Clostridioides difficile
lysins and experimental comparison with highly active benchmarks
. Biotechnology and Bioengineering 118:7, pages 2482-2492.
Crossref
Crossref
Belen G. Hernandez, Akhil A. Vinithakumari, Brett Sponseller, Chandra Tangudu & Shankumar Mooyottu. (2020) Prevalence, Colonization, Epidemiology, and Public Health Significance of Clostridioides difficile in Companion Animals. Frontiers in Veterinary Science 7.
Crossref
Crossref
Huiluo Cao, Sally Cheuk-Ying Wong, Wing-Cheong Yam, Melissa Chun-Jiao Liu, Kin-Hung Chow, Alan Ka-Lun Wu & Pak-Leung Ho. (2019) Genomic investigation of a sequence type 67 Clostridium difficile causing community-acquired fulminant colitis in Hong Kong. International Journal of Medical Microbiology 309:5, pages 270-273.
Crossref
Crossref